The Anh Nguyen, Dang Khoa Tran, Hoai Linh Vu, Huy Phuong Nguyen, Ngoc Duong Vu, Quang Loc Tran, Le Hoang Dat
Intensive Care Unit, Friendship Hospital, Hanoi, Vietnam.
Department of Radiology, Friendship Hospital, Hanoi, Vietnam.
Radiol Case Rep. 2024 Sep 23;19(12):6157-6160. doi: 10.1016/j.radcr.2024.08.131. eCollection 2024 Dec.
Dual antiplatelet therapy is commonly used to treat or prevent thromboembolic events in patients with deep vein thrombosis, pulmonary embolism, atrial fibrillation, in patients after coronary artery stenting, cerebral artery stenting or artificial heart valves, etc. Although they significantly reduce the morbidity and mortality from thromboembolic events, dual antiplatelet therapy is associated with the risk of bleeding, which can be life-threatening. Gastrointestinal bleeding is one of the most common and dangerous events when using dual antiplatelet therapy for a long time. According to studies, nearly half of the major bleeding cases related to dual antiplatelet therapy arise from the gastrointestinal (GI) tract. We report the case of a 74-year-old female patient with lower gastrointestinal bleeding after using dual antiplatelet therapy that was successfully treated endovascularly with a coil.
双联抗血小板治疗常用于治疗或预防深静脉血栓形成、肺栓塞、心房颤动患者，以及冠状动脉支架置入、脑动脉支架置入或人工心脏瓣膜置换术后患者的血栓栓塞事件等。尽管双联抗血小板治疗可显著降低血栓栓塞事件的发病率和死亡率，但它也存在出血风险，这可能危及生命。长期使用双联抗血小板治疗时，胃肠道出血是最常见且危险的事件之一。根据研究，与双联抗血小板治疗相关的主要出血病例中，近一半发生在胃肠道。我们报告了一例74岁女性患者，在使用双联抗血小板治疗后发生下消化道出血，经血管内使用弹簧圈成功治疗。
